Gender differences in atrial fibrillation risk factors, presentation, and management in Tabuk, Kingdom of Saudi Arabia

Authors

  • Hyder Osman Mirghani Associate Professor of Internal Medicine and Endocrine, Medical Department, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia

Keywords:

Gender difference, Atrial fibrillation, Saudi Arabia

Abstract

Background: There is a lack of data regarding gender differences in atrial fibrillation presentation and clinical characteristics in Saudi Arabia.  Objective: To assess gender differences in atrial fibrillation risk factors, presentation, and management strategy in Tabuk. Methods: This retrospective cross-sectional study was conducted in King Fahad Specialist Hospital in Tabuk City, Saudi Arabia. The medical records of all patients with atrial fibrillation in the years 2016 and 2017 were approached using a structured questionnaire to collect demographic factors, atrial fibrillation risks including diabetes, hypertension, ischemic heart disease, valvular heart disease, respiratory diseases (Bronchial Asthma, chronic obstructive airways disease, and pulmonary fibrosis), cardiomyopathy, thyrotoxicosis, and congenital heart disease. The different types of atrial fibrillation, management strategy, and complications were also reported. IBM-SPSS version 20 was used for data analysis. The Chi-square test was applied to compare men and women. Results: There were 93 patients with atrial fibrillation (59.2% males), hypertension, diabetes, ischemic heart disease, cardiomyopathy, thyrotoxicosis, congenital heart disease, and valvular heart disease was evident in 72%, 31.2%, 32.1%, 9.7%, 2.2%, 2.2%, and 10.7% respectively, while respiratory diseases, chronic atrial fibrillation, rate control strategy, and stroke were reported in 7.6%, 70.9%, 68.8%, and 16.1% of patients respectively.  Women were older and had more paroxysmal atrial fibrillation with significant statistical differences (p=0.010). No significant differences were evident regarding other characteristics. Conclusion: No significant differences were found between males and females except age and paroxysmal atrial fibrillation, which were higher among women.

References

Piccinocchi G, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, et al. Diagnosis and management

of atrial fibrillation by primary care physicians in Italy: a retrospective, observational analysis. Clin Drug

Investig. 2012; 32(11): 771-7. doi: 10.1007/s40261-012-0005-5. PMID: 23018284 PMCID: PMC3693438.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, et al. A prospective survey in

European Society of Cardiology member countries of atrial fibrillation management: baseline results of

EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace.

; 16(3): 308-19. doi: 10.1093/europace/eut373. PMID: 24351881.

Hersi A, Abdul-Moneim M, Almous'ad A, Al-Samadi F, AlFagih A, Sweidan R. Saudi Atrial Fibrillation

Survey: national, observational, cross-sectional survey evaluating atrial fibrillation management and the

cardiovascular risk profile of patients with atrial fibrillation. Angiology. 2015; 66(3): 244-8. doi:

1177/0003319714529180. PMID: 24687415.

Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin North Am. 2008; 92:

-40. doi: 10.1016/j.mcna.2007.09.002. PMID: 18060995, PMCID: PMC2245891.

Bin Salih SA, Showlag MS, Al-Qahtani MA, Taha A, Yousuf M, Abdullah M. Clinical characteristics of

patients with atrial fibrillation at a tertiary care hospital in the central region of Saudi Arabia. J Family

Community Med. 2011; 18(2): 80-4. doi: 10.4103/2230-8229.83374. PMID: 21897916, PMCID:

PMC3159233.

Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, et al. Atrial fibrillation as risk

factor for cardiovascular disease and death in women compared with men: systematic review and meta- analysis of cohort studies. BMJ. 2016; 532: h7013. doi:10.1136/bmj.h7013. PMID: 26786546 PMCID:

PMC5482349.

Pancholy SB, Sharma PS, Pancholy DS, Patel TM, Callans DJ, Marchlinski FE. Meta-analysis of gender

differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated

with oral anticoagulants. Am J Cardiol. 2014; 113: 485–90. doi:10.1016/j.amjcard.2013.10.035. PMID:

Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, et al. Risk assessment for incident

heart failure in individuals with atrial fibrillation. Eur J Heart Fail. 2013; 15: 843–9.

doi:10.1093/eurjhf/hft041. PMID: 23594831, PMCID: PMC3858114.

Gutierrez C, Blanchard DG. Diagnosis and Treatment of Atrial Fibrillation. Am Fam Physician. 2016;

(6): 442-52. PMID: 27637120.

Sethi NJ, Feinberg J, Nielsen EE, Safi S, Gluud C, Jakobsen JC. The effects of rhythm control strategies

versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis

and Trial Sequential Analysis. PLoS One. 2017; 12(10): e0186856. doi: 10.1371/journal.pone.0186856.

PMID: 29073191, PMCID: PMC5658096.

Vázquez Ruiz de Castroviejo E, MárquezGarcía A, Fajardo Pineda A, Lozano Cabezas C, Guzmán Herrera

M, Ramírez Moreno A, et al. Patterns of clinical presentation of atrial fibrillation in hospitalized patients.

Rev Esp Cardiol. 2003; 56(12): 1187-94. doi: 10.1016/S0300-8932(03)77037-7.

Chiang CE, Naditch-Brûlé L, Murin J, Goethals M, Inoue H, O'Neill J, et al. Distribution and risk profile of

paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillationinternational registry. Circ Arrhythm

Electrophysiol. 2012; 5(4): 632-9. doi: 10.1161/CIRCEP.112.970749. PMID: 22787011.

Schnabel RB, Pecen L, Ojeda FM, Lucerna M, Rzayeva N, Blankenberg S, et al. Gender differences in

clinical presentation and 1-year outcomes in atrial fibrillation. Heart. 2017; 103(13): 1024-30. doi:

1136/heartjnl-2016-310406.

Potpara TS, Marinkovic JM, Polovina MM, Stankovic GR, Seferovic PM, Ostojic MC, et al. Genderrelated differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial

fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol. 2012; 161(1):

-44. doi: 10.1016/j.ijcard.2011.04.022.

Lip GY, Laroche C, Boriani G, Cimaglia P, Dan GA, Santini M, et al. Sex-related differences in

presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro

Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015; 17(1): 24-31. doi:

1093/europace/euu155. PMID: 24957921.

Shehab A, Zubaid M, Bhagavathula AS, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, et al. Sex

differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey

of atrial fibrillation events (Gulf SAFE).PLoS One. 2017; 12(5): e0175405. doi:

1371/journal.pone.0175405. PMID: 28520719, PMCID: PMC5435140.

Downloads

Published

2021-12-14